ADMA
ADMA Biologics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.46B
P/E Ratio
17.67
EPS
$0.60
Beta
0.82
52W High
$24.17
52W Low
$7.21
50-Day MA
$12.87
200-Day MA
$15.95
Dividend Yield
—
Profit Margin
28.80%
Forward P/E
10.79
PEG Ratio
0.00
About ADMA Biologics Inc
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.
Fundamentals
| Revenue (TTM) | $510.17M |
| Gross Profit (TTM) | $292.76M |
| EBITDA | $199.54M |
| Operating Margin | -123.40% |
| Return on Equity | 35.60% |
| Return on Assets | 21.50% |
| Revenue/Share (TTM) | $2.14 |
| Book Value | $2.01 |
| Price-to-Book | 5.31 |
| Price-to-Sales (TTM) | 4.83 |
| EV/Revenue | 4.949 |
| EV/EBITDA | 12.76 |
| Quarterly Earnings Growth (YoY) | -52.80% |
| Quarterly Revenue Growth (YoY) | 15.90% |
| Shares Outstanding | $232.32M |
| Float | $233.02M |
| % Insiders | 1.85% |
| % Institutions | 97.43% |
Historical Volatility
HV 10-Day
30.06%
HV 20-Day
38.93%
HV 30-Day
99.13%
HV 60-Day
77.61%
HV Rank
92.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($20.67 target)
2
Buy1
HoldData last updated: 4/30/2026